EGF and cancer: Germline mutations in the NOTCH pathway are associated with a variety of non-cancer related hereditary syndromes, but both activating mutations in the negative regulatory region or PEST domain and inactivating mutations in epidermal growth factor-like repeats of the extracellular domains should be interpreted as pathogenic within the context of cancer.